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When HL-60 cells were cultivated with synthetic sialyl glycolipids, sialo-cholesterol and sialo-diglyceride, the cells were found to be differentiated 
into mature granulocytes on morphological and functional criteria. The differentiation of cells was accompanied by inhibition of cell proliferation. 
The differentiation-inducing activity of sialo-cholesterol was greater than that of sialo-diglyceride on a molar basis, and the a-anomer of each com- 
pound was more potent than the p-anomer, suggesting that the stereospecific structure of the compounds is important for the differentiation-in- 
ducing activity. 
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1. INTRODUCTION 
Recent studies indicate that sialyl glycolipids play an 
important role in the proliferation and the differentia- 
tion of various types of cells, including fibroblasts, lym- 
phocytes, astroglial and leukemic cells [l-5]. We have 
recently demonstrated that neolacto series gangliosides 
induce granulocytic differentiation not only of the 
human myelogenous leukemia cell line HL-60 cells but 
also of a subline of HL-60 cells resistant o the differen- 
tiation induction by retinoic acid [4,5]. Taking into ac- 
count that neolacto series gangliosides are natural com- 
ponents of granulocyte plasma membrane, these obser- 
vations indicate that neolacto series gangliosides could 
be candidates for the differentiation therapy for certain 
types of myelogenous leukemia. Then, we searched for 
synthetic sialyl glycolipids mimicking the action of 
neolacto series gangliosides. In this paper, we show that 
synthetic sialo-cholesterol and sialo-diglyceride are able 
to induce granulocytic differentiation of HL-60 cells. 
differentiation, HL-60 cells were seeded at approximately 2x lo5 
cells/ml and grown in the presence or absence of sialyl glycolipids. 
Cell viability was determined by the erythrosine B dye exclusion test. 
2.2. Chemicals 
Alpha-sialo-cholesterol (a-o-N-acetylneuraminyl cholesterol, LY- 
sialo-diglyceride (3-0-a-n-N-acetylneuraminyl-1,2-di-o-tetracecyl- 
glycerol) and their ,&anomers were synthesized as described [6]. 
Cytochrome c type III, N-formyl-methionyl-leucyl-phenylalanine 
(FMLP), phorbol myristate acetate (PMA) and superoxide dismutase 
were purchased from Sigma Chemical Co., St. Louis, MO. 
2.3. Determination of cell differentiation 
2. MATERIALS AND METHODS 
2.1. Cells and ceil culture 
HL-60 cells (a wild-type, mycoplasma-free) were grown in a serum- 
free synthetic medium (DME/F12) as described [5]. For induction of 
For morphological assessment of the cells, Cytospin slide prepara- 
tions were prepared using a Schandon Cytospin centrifuge (Schandon 
Southern Instruments, Inc., Sewickley, PA) and stained with Wright- 
Giemsa. The morphological assessment was performed under a light 
microscope. Surface membrane antigens were assessed by indirect im- 
munofluorescence and cytofluorometry in an Ortho Spectrum III 
(Ortho Diagnostic Systems, Westwood, MA) using anti-OKMl 
(CDll) 17). anti-OKB2 (CD24) [8] (Ortho Diagnostic Systems) and 
anti-LeuMl (CD15) [9] (Becton Dickinson Immunocytometry 
Systems, CA) monoclonal antibodies, and fluorescein isothiocyanate- 
conjugated goat F(ab’)z anti-mouse IgG or IgM antibodies. Mouse 
IgG was used as a negative control and a gate was used. The activity 
of non-specific esterase and nitroblue tetrazolium reduction was 
determined as described [5]. Superoxide (05) release was assayed 
spectrophotometrically by superoxide dismutase-inhibitable reduc- 
tion of ferricytochrome c, and the continuous assay was performed in 
a Hitachi 557 spectrophotometer (a double wavelength spec- 
trophotometer, Hitachi Ltd., Tokyo) as described [lo]. 
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3. RESULTS AND DISCUSSION 
Abbreviations: FMLP, N-formyl-methionyl-leucyl-phenylalanine; 
PMA, phorbol myristate acetate 
When HL-60 cells were cultivated with cu-sialo- 
cholesterol (0.5 PM), an apparent morphological 
change reflecting differentiation along the granulocytic 
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Fig. 1. Light microscopic pictures of HL-60 cells cultivated with jai cu-sialo-choksterol fD.S~hJf or (C) ~y-sjaio-digi~c~r~d~ tl5,&$) for 6 days. (A) 
controt cells. 
lineage was observed on day 5-6 (Fig. 1). Concomitant- 
ly with morphological changes, the number of cells 
strongly postive for the granulocytic lineage-specific 
naphthol AS-D chforoacetate esterase activity was in- 
creased (Table I). As shown in Fig. 2, HL-60 cells dif- 
ferentiated by cw-sialo-cholesterol showed the increased 
expression of surface membrane antigens recognized by 
anti-OKMl and anti-OKB2. Anti-OKMl reacts on 
granulocytes and monocytes [7f, and anti-OKB2 reacts 
on granulocytes but not on monocytes [S]. Thus, the 
findings with non-specific esterase activity and surface 
membrane antigens indicated that HL-60 celIs differen- 
tiated by cu-sialo-cholesterol were granulocytic cells. 
When HL-60 cells were maintained in a serum-free syn- 
thetic medium instead of a serum-containing medium, 
the cells were found to be differentiated functionally to 
Table I 
The activity of non-specific esterase and nitroblue tetrazolium reduc- 
tion in WI_.-60 cells differentiated by cu-sialo-cholesterol 
Naphthol AS-D chloroacerare ~Naph- Nitrnbiue 
esterase thy1 tetrazo- 
+ t-t +++ 
butyratc hum 
esterase reduction 
Control 
cu-Sialo- 
-_I. 
20.0 58.2 9.6 12.2 12.5 
chofesterol 12.2 48,4 31.0 x.4 62.4 
HL-SO cetls were cultivated with O.S,Al cu-sialo-chotestcrai for 5 days. 
The cells positive for naphthol AS-D chloroacetate &erase activity 
were divided into 3 classes according to the staining intensity; stained 
patchily (-t ), light blue (+ +) and dark blue (+ + +). Values repre- 
senr the means of 4 experiments for the esterase activity and of two 
experiments for the nitrobfue tgtrazo~iu~-seducing activity, and are 
expressed as the percentage oE celk. The statisrical analysis revealed 
that the number of cells strongly positive (i + + ) for the naphthol 
AS-D chloroacetate esterase activity was significantly (piO.01) in- 
creased by the treatment with cu-sialo-cholesterol 
86 
some extent (data not shown), which may partly explain 
the increased expression of 0KB2 on control cells used 
in the present experiments. LeuMl was expressed on all 
immature HL-60 cells and the expression of LeuMl was 
unchanged during the differc~tiation of EL-60 ceils, 
The respiratory burst activity was increased in HL-60 
cells differentiated by a-sialo-cholesterol when assessed 
a-siafrt-chotestefol controf 
p* SxtD’~N1 
4 
5x lo-*u 
5x lo-‘M 
lXliY% 
3 1 2 3 45 
Days in Culture 
oc- 1. . ..-+ 
0 10-‘“fO-s 10-B lo-’ lcrS 
a-sialo-cholesterol (M) 
Fig. 2. Inhibition of cell proliferation and induction of mature 
granulocyte antigens by a-sialo-cholesteral. Upper: HI,-60 cells were 
cultivated with various concentrations of a-sialo-cholesterol, and 
viable cells were counred on indicared cutrure days. Each point 
represenrf the mean of 3 experiments. Lower: N-60 ceils were 
cultivated with various concentrations of lu-sialo-cholesterol for 5 
days, and the surface membrane antigens were assessed by cyto- 
fluorometry. Each point representa the mean of 3 experiments. 
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Fig. 3. Time courses of 0; release in HL-60 cells cultivated with Lu-sialo-cholesterol (0.5 ,uM) or cu-sialo-diglyceride (15 pM) for 6 days. The cell 
suspension (5 x 10’ cells/ml) in Hanks’ balanced salt solution was added to a I-ml cuvette containing 66pM ferricytochrome c, and the absorbance 
change at 550-540 nm was followed on the recorder. PMA (100 ng/ml) and FMLP (1 ,xX) were used as stimuli. 
by the nitroblue tetr~o~ium-reducing activity and the 
02 -releasing capacity (Table 1, Figs 3 and 4). The time 
courses of 0: release in mature HL-60 cells stimulated 
by PMA or FMLP, a chemotactic peptide, were similar 
to those in normal granulocytes, and the amount of 02 
release in mature HL-60 cells was almost comparable to 
that in normal granulocytes (Fig. 3) [lo]. HL-60 cells 
were also differentiated into granulocytic cells mor- 
phologically and functionally when the cells were 
cultivated with a-sialo-diglyceride or the &anomer of 
sialo-cholesterol or sialo-diglyceride for 5-6 days 
(Figs 1, 3 and 4; the pictures were not shown for the P- 
anomers). The differentiation-inducing activity of 
sialo-cholesterol was greater than that of sialo- 
diglyceride on a molar basis, and the cu-anomer of each 
compound was more potent than the&anomer (Fig. 4). 
These findings suggest hat the stereospecific structure 
of the compounds is important for exhibiting the 
differentiation-inducing activity. The differentiation of 
Fig. 4. Or release in HL-60 cells differentiated by cy- and p-anomers 
of sialo-cholesterol and siato-digIyceride. HL-60 cells were cuhivated 
with various concentrations of each compound for 6 days, and 0; 
release stimulated by PMA (100 ng/ml) was assayed. 
HL-60 cells by all these sialyl glycolipids was accom- 
panied by inhibition of cell proliferation (Fig. 2; data 
not shown for the other compounds). The higher con- 
centrations of d+sialo-cholesterol (> 1 PM) were toxic to 
the cells. Neither free sialic acid (2pM) nor cholesterol 
(2 yM) by itself induced the differentiation of HL-60 
cells. 
The differentiation-inducing activity of sialo- 
cholesterol or sialo-diglyceride has been recently 
demonstrated in neuronal cells; a mouse neuroblastoma 
cell line (Neuro 2a) [ 1 l] and rat normal glioblasts [ 12) or 
astroblasts [13]. The present experiments demonstrated 
that sialo-cholesterol and sialo-diglyceride also acted on 
human hematopoietic ells and induced the differentia- 
tion of leukemic cells. Although the precise mechanisms 
by which these sialyl glycolipids induce the differentia- 
tion are unknown, the studies with rat glioblasts or 
astroblasts suggest that sialo-cholesterol, like gan- 
gliosides, acts directly on the plasma membrane [12,131. 
‘The existence of protein kinases regulated by gan- 
gliosides and the ganglioside-specific binding protein is 
reported in guinea pig and rat brain [ 14-161. Thus, it is 
possible that sialo-cholesterol and sialo-diglyceride may 
alter the membrane microenvironment o affect the 
protein kinase activity or may produce intracellular 
messengers that are not yet identified. The in vivo ef- 
fects of these compounds on leukemic cells are now 
under investigation at our laboratory by using nude 
mice to which human leukemic cells are transplanted. 
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